Experts Debate Cannabis Use for GI Disorders
Medical researchers addressed the complex impact of cannabis on gastrointestinal health at a national scientific meeting.
Updated on Oct. 30, 2026 in Substance Abuse
Live Poll
Do you believe the medical benefits of cannabis outweigh the potential for long-term health risks?
Medical experts gathered at the American College of Gastroenterology Annual Scientific Meeting in Nashville to discuss the clinical effects of cannabis on gastrointestinal disorders. The discussion highlighted how cannabis use can decrease gastric tone and colonic motility while addressing increasing patient interest in using the substance for pain and nausea.
Why it matters
As more patients turn to cannabis for gastrointestinal relief, medical professionals are working to better understand its systemic effects and risks. This clinical focus aims to improve documentation and care for conditions like cannabinoid hyperemesis syndrome.
Cannabis products currently available in dispensaries contain an average THC concentration of 25%, significantly higher than the 4% seen in historical products. Research suggests that neural receptor recovery after total cannabis abstinence typically takes 4 weeks.
The players
American College of Gastroenterology
This is a professional medical association that promotes the study and clinical practice of gastroenterology in the United States.
The details
Cannabinoid receptors are present in the neural circuits responsible for nausea, and chronic daily use is linked to the downregulation of type 1 receptors. Beyond the gastrointestinal effects, experts noted that cannabis use is associated with side effects such as anxiety, psychosis, sleep disorders, and cannabis use disorder.
Timeline
An ICD-10 code for cannabinoid hyperemesis syndrome was officially established in October 2025.
The ACG Annual Scientific Meeting debate took place in Nashville in October 2026.
Health Landscape
The introduction of an ICD-10 code for cannabinoid hyperemesis syndrome in 2025 formalizes the diagnostic recognition of this condition within the global healthcare system. This shift allows for more standardized tracking and clinical understanding of the syndrome as cannabis use becomes more prevalent.
Patients who use cannabis for gastrointestinal relief should be aware of the potential for cannabinoid hyperemesis syndrome and other associated psychiatric side effects. Consulting with a healthcare provider is essential to understand how cannabis interacts with their specific condition and neural receptor sensitivity.
The takeaway
Medical experts emphasize that the high THC concentrations in modern products present unique challenges for gastrointestinal health management. Patients should discuss the risks of long-term use and potential symptom overlap with their doctors to ensure safe treatment plans.
Further reading
For more context on the clinical implications of substance usage, explore the Substance Abuse section.
Source note: This article includes information reported by Healio.
Live Poll
Do you believe the medical benefits of cannabis outweigh the potential for long-term health risks?
